MYUNGMOON Pharm co.,Ltd
017180.KS
Get informed when a big investor buys or sells
+ FollowMarket Cap$42.99B
Close$
Share Statistics
| Market cap | $42.99 Billion |
|---|---|
| Enterprise Value | $108.20 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $56.7 |
| Beta | 0.28 |
| Outstanding Shares | 33,428,331 |
Return
| Return on Equity | -1.71% |
|---|---|
| Return on Assets | -0.56% |
| Return on Invested Capital | 1.04% |
Valuation & Multiples
| P/E Ratio | -21.31 |
|---|---|
| PEG | 15.58 |
| Price to Sales | 0.21 |
| Price to Book Ratio | 0.42 |
| Enterprise Value to Revenue | 0.54 |
| Enterprise Value to EBIT | 55.16 |
| Enterprise Value to Net Income | -65 |
| Total Debt to Enterprise | 0.83 |
| Debt to Equity | 0.91 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About MYUNGMOON Pharm co.,Ltd
309 employees
CEO: Cheol-han Bae MYUNGMOON Pharm Co., Ltd. operates as a pharmaceutical enterprise, comprehensively handling the research, development, production, distribution, and commercialization of medicinal products. Its business activities extend across South Kor...